You are here
Big pharma turns to artificial intelligence to speed up drug discovery process
THE world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with Glaxo-SmithKline unveiling a new US$43 million deal in the field on Sunday.
Other pharmaceutical giants including Merck & Co,
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org